Effects of Taurine on treatment process of ulcerative colitis patients.
Phase 2
Completed
- Conditions
- ulcerative colitis.Ulcerative colitis
- Registration Number
- IRCT201101275704N1
- Lead Sponsor
- Vice Chancellor for research of Tabriz University of Medical Sciences (Liver and Gastrointestinal di
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
patients of both sex, who are recently diagnosed with ulcerative colitis and are being treated for a maximum of 1 month; or their disease is not controlled by routine treatments.
Exclusion criteria:pregnant women; presence of signs and symptoms for less than 2 weeks; diagnosed with crohn's disease; patients who receive supplements; patients with systemic disease such as tumor or perforation; patients with other inflammatory disease or history of surgery
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disease signs and symptoms. Timepoint: Prior to intervention and 8 weeks after intervention. Method of measurement: Standard questionaire.
- Secondary Outcome Measures
Name Time Method